![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/00 | |
A61K 31/4458 | |||
A61K 31/137 | |||
A61P 3/04 | |||
A61P 25/00 | |||
C12N 9/24 | |||
A61K 47/58 |
(11) | Number of the document | 2726066 |
(13) | Kind of document | T |
(96) | European patent application number | 12805240.4 |
Date of filing the European patent application | 2012-06-28 | |
(97) | Date of publication of the European application | 2014-05-07 |
(45) | Date of publication and mention of the grant of the patent | 2021-03-31 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2012/044698 |
Date | 2012-06-28 |
(87) | Number | WO 2013/003622 |
Date | 2013-01-03 |
(30) | Number | Date | Country code |
201161502189 P | 2011-06-28 | US | |
201161528554 P | 2011-08-29 | US |
(72) |
TENGLER, Mark, US
MCMAHEN, Russell, US
|
(73) |
Neos Therapeutics, LP,
2940 North Highway 360, Grand Prairie, Texas 75050,
US
|
(54) | DOSAGE FORMS OF AMPHETAMINE FOR ORAL ADMINISTRATION |
DOSAGE FORMS OF AMPHETAMINE FOR ORAL ADMINISTRATION |